Trial Profile
Quality of life of patients with actinic keratoses and/or a superficial basal cell carcinoma treated with Imiquimod 5% cream.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Actinic keratosis; Basal cell cancer
- Focus Therapeutic Use
- Sponsors Meda Pharmaceuticals
- 30 Jul 2011 New trial record